These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9596493)

  • 1. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study.
    Smith W; Mitchell P; Leeder SR; Wang JJ
    Arch Ophthalmol; 1998 May; 116(5):583-7. PubMed ID: 9596493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.
    Tan JS; Mitchell P; Smith W; Wang JJ
    Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris color, skin sun sensitivity, and age-related maculopathy. The Blue Mountains Eye Study.
    Mitchell P; Smith W; Wang JJ
    Ophthalmology; 1998 Aug; 105(8):1359-63. PubMed ID: 9709743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family history and age-related maculopathy: the Blue Mountains Eye Study.
    Smith W; Mitchell P
    Aust N Z J Ophthalmol; 1998 Aug; 26(3):203-6. PubMed ID: 9717749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and age-related maculopathy. The Blue Mountains Eye Study.
    Smith W; Mitchell P; Leeder SR
    Arch Ophthalmol; 1996 Dec; 114(12):1518-23. PubMed ID: 8953988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal vessel wall signs and the 5 year incidence of age related maculopathy: the Blue Mountains Eye Study.
    Wang JJ; Mitchell P; Rochtchina E; Tan AG; Wong TY; Klein R
    Br J Ophthalmol; 2004 Jan; 88(1):104-9. PubMed ID: 14693785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal vessel signs and 10-year incident age-related maculopathy: the Blue Mountains Eye Study.
    Liew G; Kaushik S; Rochtchina E; Tan AG; Mitchell P; Wang JJ
    Ophthalmology; 2006 Sep; 113(9):1481-7. PubMed ID: 16828507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen and other cardiovascular disease risk factors and cataract.
    Goodrich ME; Cumming RG; Mitchell P; Koutts J; Burnett L
    Ophthalmic Epidemiol; 1999 Dec; 6(4):279-90. PubMed ID: 10544342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin concentrations are decreased and correlated with disease severity in age-related macular degeneration: a preliminary study.
    Evereklioglu C; Doganay S; Er H; Cekmen M; Ozerol E; Otlu B
    Eye (Lond); 2003 Apr; 17(3):350-5. PubMed ID: 12724698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors associated with age-related macular degeneration: the Tromsø Study.
    Erke MG; Bertelsen G; Peto T; Sjølie AK; Lindekleiv H; Njølstad I
    Acta Ophthalmol; 2014 Nov; 92(7):662-9. PubMed ID: 24460653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers in age-related maculopathy: cross-sectional analysis from the Muenster Aging and Retina Study.
    Dasch B; Fuhs A; Behrens T; Meister A; Wellmann J; Fobker M; Pauleikhoff D; Hense HW
    Arch Ophthalmol; 2005 Nov; 123(11):1501-6. PubMed ID: 16286611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors (ACEIs) and age-related maculopathy (ARM): cross-sectional findings from the Blue Mountains Eye Study.
    Wu KH; Wang JJ; Rochtchina E; Foran S; Ng MK; Mitchell P
    Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):298-303. PubMed ID: 15115451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating inflammatory markers and hemostatic factors in age-related maculopathy: a population-based case-control study.
    Wu KH; Tan AG; Rochtchina E; Favaloro EJ; Williams A; Mitchell P; Wang JJ
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1983-8. PubMed ID: 17460250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cataract and age-related maculopathy: the Blue Mountains Eye Study.
    Wang JJ; Mitchell PG; Cumming RG; Lim R
    Ophthalmic Epidemiol; 1999 Dec; 6(4):317-26. PubMed ID: 10544345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary antioxidants and age-related maculopathy: the Blue Mountains Eye Study.
    Smith W; Mitchell P; Webb K; Leeder SR
    Ophthalmology; 1999 Apr; 106(4):761-7. PubMed ID: 10201600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study.
    Wang JJ; Mitchell P; Smith W; Gillies M; Billson F;
    Ophthalmic Epidemiol; 2003 Feb; 10(1):37-48. PubMed ID: 12607158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction.
    Lip PL; Blann AD; Hope-Ross M; Gibson JM; Lip GY
    Ophthalmology; 2001 Apr; 108(4):705-10. PubMed ID: 11297487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of vitamin and zinc supplements and age-related maculopathy: the Blue Mountains Eye Study.
    Kuzniarz M; Mitchell P; Flood VM; Wang JJ
    Ophthalmic Epidemiol; 2002 Oct; 9(4):283-95. PubMed ID: 12187426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study.
    Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P
    Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and determinants of age-related macular degeneration in the 50 years and older population: a hospital based study in Maharashtra, India.
    Kulkarni SR; Aghashe SR; Khandekar RB; Deshpande MD
    Indian J Ophthalmol; 2013 May; 61(5):196-201. PubMed ID: 23571245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.